{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","description":"This cluster of papers focuses on the role of erythropoietin and its derivatives in the treatment and management of various diseases, including anemia, chronic kidney disease, heart failure, stroke, and cancer. It explores the use of erythropoiesis-stimulating agents, neuroprotective effects, and the impact on hypoxia-inducible factors. Additionally, it addresses the association with iron deficiency and cardiovascular disease.","keywords":[{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.4436},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.7116},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.7578},{"id":"https://openalex.org/keywords/erythropoiesis","display_name":"erythropoiesis","score":0.2823},{"id":"https://openalex.org/keywords/recombinant-human-erythropoietin","display_name":"recombinant human erythropoietin","score":0.6772},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.3476},{"id":"https://openalex.org/keywords/erythropoietin-receptor","display_name":"erythropoietin receptor","score":0.5945},{"id":"https://openalex.org/keywords/darbepoetin-alfa","display_name":"darbepoetin alfa","score":0.7622},{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.7499},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.7421},{"id":"https://openalex.org/keywords/anemia-management","display_name":"anemia management","score":0.379},{"id":"https://openalex.org/keywords/intravenous-iron","display_name":"intravenous iron","score":0.2353},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.5004},{"id":"https://openalex.org/keywords/cancer-related-anemia","display_name":"cancer-related anemia","score":0.6258},{"id":"https://openalex.org/keywords/hemoglobin-target","display_name":"hemoglobin target","score":0.7061},{"id":"https://openalex.org/keywords/erythropoietin-resistance","display_name":"erythropoietin resistance","score":0.7354},{"id":"https://openalex.org/keywords/erythropoietin-therapy","display_name":"erythropoietin therapy","score":0.7209},{"id":"https://openalex.org/keywords/epoetin","display_name":"epoetin","score":0.6909},{"id":"https://openalex.org/keywords/epoetin-beta","display_name":"epoetin beta","score":0.8285},{"id":"https://openalex.org/keywords/roxadustat","display_name":"roxadustat","score":0.6205},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor","display_name":"hypoxia-inducible factor prolyl hydroxylase inhibitor","score":0.8289},{"id":"https://openalex.org/keywords/erythropoietin-deficiency","display_name":"erythropoietin deficiency","score":0.7972},{"id":"https://openalex.org/keywords/serum-erythropoietin","display_name":"serum erythropoietin","score":0.7013},{"id":"https://openalex.org/keywords/erythropoiesis-regulation","display_name":"erythropoiesis regulation","score":0.7665},{"id":"https://openalex.org/keywords/cfu-e","display_name":"CFU-E","score":0.222}],"legacy_keywords":"Anemia; Chronic Kidney Disease; Heart Failure; Erythropoiesis-Stimulating Agents; Neuroprotection; Hypoxia-Inducible Factors; Cancer Treatment; Iron Deficiency; Stroke; Cardiovascular Disease","ids":{"openalex":"https://openalex.org/T11534","wikipedia":"https://en.wikipedia.org/wiki/Erythropoietin"},"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"},"siblings":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research"},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation"},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders"},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments"},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments"},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms"},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments"},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research"},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research"},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion"},{"id":"https://openalex.org/T12548","display_name":"Hemostasis and retained surgical items"}],"works_count":44761,"cited_by_count":701500,"works_api_url":"https://api.openalex.org/works?filter=topics.id:T11534","updated_date":"2026-10-20T03:01:21","created_date":"2024-01-23T15:27:10"}